Afshin Mirzaei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Afshin Mirzaei has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Arezou Soltanattar
Islamic Azad University of Medical Sciences, Yazd, Islamic Republic of Iran
1 shared publication - Arman Shafiee
Alborz University of Medical Sciences
1 shared publication - Masoud Dehbozorgi
Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen (RWTH Aachen), Aachen City, Germany
1 shared publication - Mohammad Ali Rafiei
Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
1 shared publication - Saba Goodarzi
Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
1 shared publication - Sanam Mirzaei
Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran
1 shared publication
Latest Publications
- 24 June 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (8) , 2940-2958
Bariatric Surgery vs. Low-energy Diet and Cardiometabolic Factors: a Systematic Review and Meta-analysis
Background Bariatric surgery and low-energy diets (LED) are established interventions for weight loss and cardiometabolic risk management in individuals with obesity. This systematic review and meta-analysis compares their efficacy in improving cardiometabolic outcomes. Methods We performed a systematic search in international databases, including PubMed/MEDLINE, Embase, Scopus, and Web of Science. Cardiometabolic outcomes assessed included cardiovascular disease risk scores, body composition, lipid profiles, glycemic control, and blood pressure. Results Bariatric surgery showed superior efficacy to LEDs in reducing cardiovascular risk scores (MD − 1.94; 95% CI − 3.48 to − 0.40; p = 0.013) and waist circumference (MD − 0.59 cm; 95% CI − 1.15 to − 0.03; p = 0.040). It significantly improved lipid profiles, with reductions in total cholesterol, LDL, and triglycerides, and increased HDL (all p < 0.05). Glycemic control also improved, with lower fasting glucose, HbA1c, and HOMA-IR (all p < 0.05). Small reductions in blood pressure were noted (p < 0.05). No publication bias was detected, but heterogeneity was significant for triglycerides (p < 0.01). Conclusions Bariatric surgery offers superior and sustained improvements in cardiometabolic health compared to LED, particularly in individuals with higher baseline BMI. These findings support its role as a more effective intervention for long-term risk reduction in individuals with obesity.
- 24 June 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (8) , 2940-2958
Bariatric Surgery vs. Low-energy Diet and Cardiometabolic Factors: a Systematic Review and Meta-analysis
Background Bariatric surgery and low-energy diets (LED) are established interventions for weight loss and cardiometabolic risk management in individuals with obesity. This systematic review and meta-analysis compares their efficacy in improving cardiometabolic outcomes. Methods We performed a systematic search in international databases, including PubMed/MEDLINE, Embase, Scopus, and Web of Science. Cardiometabolic outcomes assessed included cardiovascular disease risk scores, body composition, lipid profiles, glycemic control, and blood pressure. Results Bariatric surgery showed superior efficacy to LEDs in reducing cardiovascular risk scores (MD − 1.94; 95% CI − 3.48 to − 0.40; p = 0.013) and waist circumference (MD − 0.59 cm; 95% CI − 1.15 to − 0.03; p = 0.040). It significantly improved lipid profiles, with reductions in total cholesterol, LDL, and triglycerides, and increased HDL (all p < 0.05). Glycemic control also improved, with lower fasting glucose, HbA1c, and HOMA-IR (all p < 0.05). Small reductions in blood pressure were noted (p < 0.05). No publication bias was detected, but heterogeneity was significant for triglycerides (p < 0.01). Conclusions Bariatric surgery offers superior and sustained improvements in cardiometabolic health compared to LED, particularly in individuals with higher baseline BMI. These findings support its role as a more effective intervention for long-term risk reduction in individuals with obesity.